GTR 109553263
Tenders Are Invited For Pharmaceutical Products – Open House Biologics Discount Agreements 2026-03B - Eculizumab (Incl. The Indication Gmg And Nmosd)
ICB — International Competitive Bid
Closes Aug 31, 2027
Western Europe
Tender Information
GTR Reference
109553263
Tendering Authority
Subscribe to view
Tender No
133422-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Open House Biologics Discount Agreements 2026-03B - Eculizumab (Incl. The Indication Gmg And Nmosd)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
31-08-2027
Work Detail
Pharmaceutical Products – Open House Biologics Discount Agreements 2026-03B - Eculizumab (Incl. The Indication Gmg And Nmosd). The Aim Is To Conclude Drug Discount Contracts In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Eculizumab (Including The Indication Gmg And Nmosd) As Part Of An Open House Procedure.
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
87082ac1-712f-4915-a832-9013a2603032.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.